Vijayaraghavan Rangachari

2.2k citations

35 papers · 1.6k indexed · 1 hit paper · h-index 15

Physiology top 2%
Molecular Biology top 10%
Neurology top 2%
Cellular and Molecular Neuroscience top 10%
Pharmacology top 5%

Co-authors: Terrone L. Rosenberry Dennis W. Dickson Brenda D. Moore Dana Kim Reed Todd E. Golde Francisco E. Baralle Jennifer Gass Leonard Petrucelli
Topics: Alzheimer's disease research and treatments (17 papers)Chemical Synthesis and Analysis (7 papers)Prion Diseases and Protein Misfolding (5 papers)
Cited by: Neurology Physiology
Journals: Proceedings of the National Academy of Sciences Journal of Neuroscience Biochemistry
Partner nations: United States India Switzerland

In The Last Decade

Vijayaraghavan Rangachari

34 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity

2009 484 citations Vijayaraghavan Rangachari, Todd E. Golde et al. profile →

Peers

Countries citing papers authored by Vijayaraghavan Rangachari

Since Specialization

Citations

This map shows the geographic impact of Vijayaraghavan Rangachari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vijayaraghavan Rangachari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vijayaraghavan Rangachari more than expected).

Fields of papers citing papers by Vijayaraghavan Rangachari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vijayaraghavan Rangachari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vijayaraghavan Rangachari. The network helps show where Vijayaraghavan Rangachari may publish in the future.

Co-authorship network of co-authors of Vijayaraghavan Rangachari

This figure shows the co-authorship network connecting the top 25 collaborators of Vijayaraghavan Rangachari. A scholar is included among the top collaborators of Vijayaraghavan Rangachari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vijayaraghavan Rangachari. Vijayaraghavan Rangachari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Response evaluation of locoregional therapies in combined hepatocellular–cholangiocarcinoma and intrahepatic cholangiocarcinoma versus hepatocellular carcinoma: a propensity score matched study 2021 ·Clinical Radiology ·Amar Mukund,(unknown),(unknown),Vijayaraghavan Rangachari,Yashwant Patıdar,(unknown),Ankur Jindal,Ashok Choudhury,Saggere Muralikrishna Shasthry,Shiv Kumar Sarin	8
2	A game-theoretic approach to deciphering the dynamics of amyloid- β aggregation along competing pathways 2020 ·Royal Society Open Science ·Preetam Ghosh,Pratip Rana,Vijayaraghavan Rangachari,(unknown),(unknown),Ashwin Vaidya	3
3	A network thermodynamic analysis of amyloid aggregation along competing pathways 2020 ·Applied Mathematics and Computation ·Preetam Ghosh,(unknown),Vijayaraghavan Rangachari,Anand Vaidya	4
4	Cause and consequence of Aβ – Lipid interactions in Alzheimer disease pathogenesis 2018 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Vijayaraghavan Rangachari,Dexter N. Dean,Pratip Rana,Ashwin Vaidya,Preetam Ghosh	40
5	Strain-Specific Propagation by an Amyloid-Beta Dodecamer 2017 ·Biophysical Journal ·Dexter N. Dean,Pradipta Das,Pratip Rana,(unknown),Preetam Ghosh,Sarah E. Morgan,Vijayaraghavan Rangachari	1
6	Dopamine‐induced α‐synuclein oligomers show self‐ and cross‐propagation properties 2014 ·Protein Science ·(unknown),(unknown),Sarah E. Morgan,Vijayaraghavan Rangachari	31
7	The Natural Product Betulinic Acid Rapidly Promotes Amyloid-β Fibril Formation at the Expense of Soluble Oligomers 2012 ·ACS Chemical Neuroscience ·(unknown),(unknown),Amit Kumar,Vijayaraghavan Rangachari	29
8	Inhibition of Aβ42 Peptide Aggregation by a Binuclear Ruthenium(II)−Platinum(II) Complex: Potential for Multimetal Organometallics as Anti-amyloid Agents 2010 ·ACS Chemical Neuroscience ·Amit Kumar,(unknown),(unknown),(unknown),Rahul L. Khade,Alvin A. Holder,Yong Zhang,Vijayaraghavan Rangachari	58
9	Rationally designed dehydroalanine (ΔAla)‐containing peptides inhibit amyloid‐β (Aβ) peptide aggregation 2009 ·Biopolymers ·Vijayaraghavan Rangachari,(unknown),(unknown),Brenda D. Moore,(unknown),Bernadette Cusack,Ghulam M. Maharvi,Abdul H. Fauq,Terrone L. Rosenberry	22
10	BRI2 (ITM2b) Inhibits A Deposition In Vivo 2008 ·Journal of Neuroscience ·Jungsu Kim,Virginia M. Miller,Yona Levites,(unknown),Craig Zwizinski,Brenda D. Moore,Frederick J. Troendle,Maralyssa Bann,Christophe Verbeeck,Robert Price,Lisa Smithson,Luke Sonoda,(unknown),Vijayaraghavan Rangachari,Fangdong Zou,Steven G. Younkin,N. R. Graff-Radford,Dennis W. Dickson,(unknown),Todd E. Golde	94
11	Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy 2007 ·Journal of Neuroscience ·Zdenek Berger,Hanno M. Roder,Amanda Hanna,Aaron Carlson,Vijayaraghavan Rangachari,Mei Yue,Zbigniew K. Wszołek,Karen H. Ashe,Joshua A. Knight,Dennis W. Dickson,Cathy Andorfer,Terrone L. Rosenberry,Jada Lewis,Mike Hutton,Christopher Janus	387
12	Amyloid-β(1−42) Rapidly Forms Protofibrils and Oligomers by Distinct Pathways in Low Concentrations of Sodium Dodecylsulfate 2007 ·Biochemistry ·Vijayaraghavan Rangachari,Brenda D. Moore,Dana Kim Reed,(unknown),(unknown),Erin Conboy,David E. Hartigan,Terrone L. Rosenberry	133
13	Design of Peptides with α,β-Dehydro Residues: Synthesis, Crystal Structure and Molecular Conformation of a Peptide N-Boc-Phe-ΔPhe-Ile-OCH3 2005 ·Structural Chemistry ·Vijayaraghavan Rangachari,Vivek Goel,(unknown),T.P. Singh	4
14	Sequence of Ligand Binding and Structure Change in the Diphtheria Toxin Repressor upon Activation by Divalent Transition Metals 2005 ·Biochemistry ·Vijayaraghavan Rangachari,(unknown),Ewa A. Bienkiewicz,(unknown),Luis Chel‐Guerrero,John F. Love,John R. Murphy,Timothy M. Logan	18
15	Prolylpeptide Binding by the Prokaryotic SH3-like Domain of the Diphtheria Toxin Repressor: A Regulatory Switch^, 2004 ·Biochemistry ·(unknown),Vijayaraghavan Rangachari,Ewa A. Bienkiewicz,(unknown),Nilakshee Bhattacharya,John F. Love,John R. Murphy,Timothy M. Logan	30
16	Design rules for peptides with α, β-dehydro-residues: synthesis of a model peptide Boc-Ile-ΔAla-OCH3 and its crystal structures obtained from two different solvents 2004 ·Journal of Molecular Structure ·Sharmistha Dey,Vijayaraghavan Rangachari,Vivek Goel,Saroj Kumar,Pravindra Kumar,T.P. Singh	7
17	Design of peptides with branched β‐carbon dehydro‐residues: syntheses, crystal structures and molecular conformations of two peptides, (I) N‐Carbobenzoxy‐ΔVal‐Ala‐Leu‐OCH₃ and (II) N‐Carbobenzoxy‐ΔIle‐Ala‐Leu‐OCH₃ 2003 ·Journal of Peptide Research ·Vijayaraghavan Rangachari,Pravindra Kumar,Sharmistha Dey,T.P. Singh	10
18	Design of peptides with α,β-dehydro residues: a dipeptide with a branched β-carbon dehydro residue at the (i+1) position, methylN-(benzyloxycarbonyl)-α,β-didehydrovalyl-L-tryptophanate 2001 ·Acta Crystallographica Section C Crystal Structure Communications ·Vijayaraghavan Rangachari,Pravindra Kumar,Sharmistha Dey,T.P. Singh	8
19	Design of peptides with αβ‐dehydro residues: Synthesis, crystal structure and molecular conformation of N‐Boc‐L‐Ile‐ΔPhe‐L‐Trp‐OCH₃ 1998 ·Journal of Peptide Research ·Vijayaraghavan Rangachari,Pravindra Kumar,Sharmistha Dey,T.P. Singh	10
20	A new charge density wave oxide, LiVMoO5, and its tungsten analogue obtained by topotactic reduction of LiVMO6 (M=Mo, W) brannerites 1997 ·Journal of Materials Chemistry ·J. Gopalakrishnan,(unknown),Vijayaraghavan Rangachari,(unknown)	14

About Vijayaraghavan Rangachari

Vijayaraghavan Rangachari is a scholar working on Physiology, Pharmaceutical Science and Biomaterials, having authored 35 papers that have together received 1.6k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (17 papers), Chemical Synthesis and Analysis (7 papers) and Prion Diseases and Protein Misfolding (5 papers). The work is most often cited by research in Neurology (519 citations), Physiology (860 citations) and Neurology (188 citations). Vijayaraghavan Rangachari has collaborated with scholars based in United States, India and Switzerland. Frequent co-authors include Terrone L. Rosenberry, Dennis W. Dickson, Brenda D. Moore, Dana Kim Reed, Todd E. Golde, Francisco E. Baralle, Jennifer Gass, Leonard Petrucelli, Ya-Fei Xu and Yong‐Jie Zhang. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact